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Difl'crcntialion.~timulatin8 factor (D fitctor)tleukemia nhibitory faet.r (LIF) and 11=.6 .re reported to b¢ ¢ytokl.~ h~vinn multifa~d functions 
including the induction of ditTerentiation in mouse my¢lotd leukemia M ! cells. We rter~ report that both D faetoftLIF ~.nd I L.6 inhibit the differen. 
liation of mouse teratocar¢inoma F9 cells induced by retinoie acid alone or combined with dibutyryl cAMP, Fr©m the miero~opi¢ ob~tvation 
=Ls well as Northern blot analysis usinlfl eDNA probes encoding several marker proteins for dill~rentiation or F9 cells, w~ concluded that D factor/ 
L! F and IL.6 are fu notionally closely related in the induction of differentiation i  M 1 cells~nd in the inhibition of F9 differentiation. 
Difl'¢rentiation fitctor; Leukemia inhibitory factor: IL.6; Differentiatio,; F9 cell 
1, INTRODUCTION 
D factor/LIF was originally identified as a 
differentiation.inducing factor for mouse myeloid 
leukemia cell line, MI [1], arts its eDNA was cloned and 
analyzed [2,3]. MI can be induced to differentiate into 
macrophage-like c lls by this factor. D factor/LIF is a 
cytokine with multifaced functions, including the 
maintenance of the growth of mouse ES cells [41, the 
stimulation of bone remodeling [5] and of acute-phase 
protein synthesis in hepatocytes [6], as well as the in- 
duction of differentiation i rat sympathetic neurons 
[7]. IL-6 is also multifunetional cytokine, some func- 
tions of which are similar to those of  D factor/LIF, in- 
eluding the induction of differentiation i M1 cells. It 
has not been reported, however, whether IL-6 main- 
tains the growth of undifferentiated mouse ES cells. 
The mouse teratocarcinoma cell line, F9, was induc- 
ed to differentiate into visceral endoderm-like cells by 
retinoic acid, and to parietal endodermqike c lls with 
retinoic acid in combination with dbcAMP [8]. In this 
study, we examined whether D factor/LIF and IL-6 
have any effect on the differentiation of F9 cells. 
2. MATERIALS AND METHODS 
Mouse teratocarcinoma F9 cells were maintained in Dulbecco's 
modified Eagle's medium comaining I0% foetal bovine serum (MA 
Bioproducts, Walkersville, MD), penicillin (50 units/ml), and strep. 
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tomycin (50 #g/roll, under humidified 5% COg and 95% air. Sub. 
cultures were performed every other day using 0,25% trypsin and 
I mM EDTA, For differentiation stt=dy, F9 cells were plated at a den. 
sity of 2 x t0 ~ cells/3,5 cm plastic dish and Incubated with I0"'~ M 
retinoic acid (Sigma, St, Louis, MO)alone orcombined with I0 ":= M 
dBeAMP (Wako Chemical Co, Ltd,. Osaka). Recombinant human D 
factor/LtF was added at concentrations of 5. 50 and 500 units/ml, 
and recombinant human IL-6 at concentrations of 6, 60 and 600 
units/ml, D factor/LIF was purified to homogeneity from condition- 
ed medium of CHO cells transfected with the plasmid containinl~ 
eDNA encoding human D factor/LtF [31, its specific activity was 
determined as previously reported 11] and was 100 u/nB protein, 
Recombinant human IL-6 was produced and purified in the 
laboratory of Tosoh Corp, (Kanagawa) and the specific activity was 
assessed in terms of B cell stimulatory activities utilizing the B cell line 
SKW6-CL4 as previously reported [9]. 
To prepare RNA, 4 x 10 '~ cells/t0 cm plastic dish were incubated 
for 24 h, then treated with retmoic acid alone or combined with 
dbcAMP in the presence or absence of D factor/LIF or IL-6 for 
another 48 h Total RNAs were isolated according to tl~e method of 
Chirgwin et el. [10]. Nortl~em blot analysis was performed according 
to the method previously described [111, Mouse osteonectin (Pstl 
fragment of pSE48; a kind gift from Dr Kitagawa, Nagoya Universi- 
ty), laminin (Pstl fragme.t of pSE38; from Dr Kitagawa), alkaline 
phosphatase (Pstl.Kpnl fragment of pKUTIAP; kindiy donated by 
Dr Shigesada, Institute for Virus Research, Kyoto University), type 
IV collagen (Pstl fragment of pH221; a generous gift from Dr Sakai, 
Saga Medical College) and mouse #-actin (EcoRl fragment of 
pMAd3'UT; a kind gift from Dr Sakiyama, Chiba Cancer Center 
Research Institute) were used as probes for Northern blot analysis, 
Probes were labeled with [~-~zP]dCTP (spec. act, 3000 Ci/mol) by 
the method of Feinberg etaI.  [I2], 
3. RESULTS AND DISCUSSION 
A significant characteristic of F9 cell differentiation 
was the morphological Changes. We analyzed the effect 
of D factor/LlF on the differentiation of F9 cells by 
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microscopic observation. Inhibition of the dlf'f.erentia- 
t ion in F9 cells induced by retinoic acid or retinoic acid 
and dbcAMP was observed when D rac~or/LIF was 
added to the culture (Fill, )~ This inhibiHon by D fac- 
tortL IF  was dose dependent (data not shown), and tl~e 
hish concentrations of' D factor/LIF w~re required to 
inhibit the differentiation induced wil~h rctinoi¢ acid 
than that with retinoic acid plus dbcAMP, Also, the in- 
hibitory effect of' the D factortLIF in terms of diffcren. 
tlation induction was hillher in Ih¢ ¢t)1h) lre'atcd with 
retinoic acid alone than in those cells trc~ted with 
retinoic acid and dbcAMP (data not shown), 
W'¢ quantitated the inhibi,tior~ of.differentiation by 
the Northern blot analysis, The differentiation 
markers, osteoneefin [13] and type IV collasen [8], 
were expressed in the differentiatt..d F9 Cells induced 
with retinoic a~id and with retinoic acid plus dbcAMP. 
Laminin yeas solely expressed in t he parietal endoderm- 
Fig, I. M0rphological Changes in F9 ceils ObserVed byphase conti'ast microsCopy, (A andD)Undifferentiated F9cells; (B and E) F9 ceils treated 
with: !0 =6 M retinoic acid for 3 days; and (C and F) F9 Cells treated ~ith retinoic acid (I0- ~'M) and dbcAMP (10=a M) for 3 days, D fact0r/LiF 
(500 units/ml) was absem (A, B and C):or present (D, E:and F) throughout the incubationperiod, 
i , , 
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like cells [14], Alkaline phosphatase was only e~tpressed 
in undifferentiated F9 cells {llJ. FIj. 2 shows the Inhibi- 
tion of the-differentiation of F9 cells by the addition of 
D factor/LIF, Syntheses of mRNA of osteoneclin. 
l amin in  and type IV col lagen increased in F9 cells 
treated with retinoic acid alone or combined with 
dbcAMP, D factortLIF inhibited increase in syntheses 
of their mRNA (Fig. 2a, b and c). The inhibition of the 
F9  ceil dif ferent iat ion by D fac tor l L IF  was also con- 
f i rmed by the increasett level of  a lkal ine phosphatas¢ 
mRNA in the cells treated s imultaneously  both with in. 
ducers and with D fac tor /L IF  (Fig. 2d), Northern blot 
analysis using osteonectin eDNA (the most sensitive 
di f ferent iat ion marker in our  system) as a probe reveal. 
ed the dose.dependent effect of  the D fac tor /L IF  on 
the inhib i t ion of F9 di f ferent iat ion (Fig. 3A), Using D 
fac tor /L IF  at the concentrat ion of 500 un i ts /mi ,  F9 cell 
d i f ferentiat ion was inhibited even after 4 days of in- 
cubat ion with di f ferentiat ion i ducers (Fig, 3B), 
IL-6 at the concentrat ion of  600 un i ts /ml  also in- 
hibited the differentiation of F9 cells (Fig, 4), Dose- 
dependent inhibition by IL,6 at 60-600 units/mI was 
observed by Northern blot analysis as observed for D 
factorlLIF (data not shown). Observations by phase 
contrast microscopy also confirmed the inhibitory ef- 
fect oi IL.6 on the Induct ion of  F9 cell d i f ferent iat ion 
(data not shown), 
IL -6  has similar funct ions to D fac tor /L IF ,  for ex- 
ample,  tile induct ion  of d i f ferent iat ion in mouse 
myeloid I~ukemia lvll cells [15,16] and  PC I2  cells [I7], 
and the st imulat ion of  synthesis of acute phase plasma 
proteins [61, Although D fac tor /L IF  inhibits the induc- 
tion of di f ferentiat ion i mouse ES cells [4], it was not 
yet known whether IL-6 also did so, In this,study, we 
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Fig, 2, Effect of the presence of D factor/LIF on the accumulation 
of mRNAs encoding the marker proteins f r the differentiation of F9 
cells. RNAs from undifferentiated F9 cells (lanes 1 and 4), F9 cells 
treated with 10-6M retinoic acid (lanes 2 and 5) and F9 cells treated 
with retinoic acid plus 10 -3 M dbcAMP (lanes 3 and 6). D factor/LIF 
(500 units/ml) was absent (lanes 1,2 and 3) or present(lanes 4, 5 and 
6), After separation i°70 agat'ose gels, mRNAs were analysed by 
Northern blot hybridization using several eDNA probes including 
osteoneetin (a), laminin (b), type IV collagen (c) and alkaline 
phosphatase (d), Filter was hybridized with type IV collagen, 
rehybridized with laminin and then with osteonectin, 
1 
b 
Fig. 3. Effect of the concentration f D factor/LIF on the inhibition 
of differentiation of F9 cells (A) and the time course of the 
differentiation in the presence or absence of D factor/LIF (B). (A) F9 
cells were incubated with IO -6 M retinoic acid and 10 -s M dbcAMP 
(lanes 1-4) in the presence of 5 (lane 2), 50 (lane 3), and 500 units/ml 
(lane 4) of D factor/LIF, Lane 1 shows the control without the 
addition of D factor/LIF. (B) F9 cells were incubated with 10 -6 M 
retinoic acid and 10 -3 M dbcAMP in the presence (lanes 4-6) or 
absence (lanes I-3) of 500 anits/ml D factor/LIF. RNAs were 
isolated from the cells at days'2 (lanes 1 and 4), 3 (lanes 2 and 5), and 
4 (lanes 3 and 6)~ Northern analyses were performed using eDNA 
encoding osteonectin in both A {a) and B (a), and eDNA encoding#- 
aetin A (b) and B (b) as an internal control, 
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Fig, 4. Effect or IL.6 on the differentiation of Fgcells. Northern blot 
analyses were performed aS described in Fig, 2 usinll probes for 
osteonectJn (a), laminin (b), and alkaline phosphatase ( l, Lanes I 
and 4, undifferentiated F9 cells; lanes 2 and $, F9 cells treated with 
l0 "~ M retin0ic acid for 3 days; lanes 3 and 6, F9 cells treated witlt 
10"  M retinoie acid and 10 "~ M dbcAMP for 3 days. 1L.6 (600 
units/ml) was absent (lanes I, 2 and 3) or present (hines 4, :5 and 6) 
for 3 d~ >,s. 
showed that both D factor/LIF and IL-6 inhibit the dif- 
ferentiation of F9 cells, which adds a new evidence of 
similar nature of D factor/LIF to IL-6. 
A eDNA clone encoding the 1L.6 receptor has been 
isolated [18]. The molecular size of the IL-6 receptor is 
80 kDa in the mature form, which is processed from a 
50 kDa precursor protein [19]. When the IL-6 receptor 
IS immunoprecipitated using anti.IL-6 receptor an- 
tibody after the cells are treated with IL-6, a 130 kDa 
glycoprotein (gpl30) is also precipitated with the 
80 kDa IL-6 receptor. The following observations sug- 
gest that the IL-6 receptor provides the ligand binding 
sites and that gpl30 associated with IL-6 receptor on 
the cell surface is a signal transducer. The IL-6 receptor 
has a small intracellular domain without any protein 
kinase activity which is not necessary for signal 
transduction, and soluble IL-6 receptor without an in- 
tracellular domain stimulates the growth inhibition by 
IL-6 in MI cells [19]. Although a D factor/LIF receptor 
has not been identified, it is different from that of IL-6 
since D factor/LIF did not compete for the binding of 
radiolabeled IL-6 to its receptors (our unpublished 
observations using MI cells), and likewise IL-6 did not 
compete the binding of D factor/LIF to its receptors 
[20]. [t remains to be clarified why the biological func- 
tions of D factor/LIF and IL-6 overlap each other in 
some cases as described above, and especially whether 
D factortLlF anti IL-6 utilize a common sil!n~l 
transducer such =as jpl30. 
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